KDIGO clinical practice guideline for the care of kidney transplant recipients
- PMID: 19845597
- DOI: 10.1111/j.1600-6143.2009.02834.x
KDIGO clinical practice guideline for the care of kidney transplant recipients
Abstract
The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the monitoring, management, and treatment of kidney transplant recipients is intended to assist the practitioner caring for adults and children after kidney transplantation. The guideline development process followed an evidence-based approach, and management recommendations are based on systematic reviews of relevant treatment trials. Critical appraisal of the quality of the evidence and the strength of recommendations followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. The guideline makes recommendations for immunosuppression, graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy, and other complications that are common in kidney transplant recipients, including hematological and bone disorders. Limitations of the evidence, especially on the lack of definitive clinical outcome trials, are discussed and suggestions are provided for future research.
Comment in
-
Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease.Kidney Int. 2010 Dec;78(11):1186; author reply 1186. doi: 10.1038/ki.2010.349. Kidney Int. 2010. PMID: 21076448 No abstract available.
Similar articles
-
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.Kidney Int. 2010 Feb;77(4):299-311. doi: 10.1038/ki.2009.377. Epub 2009 Oct 21. Kidney Int. 2010. PMID: 19847156
-
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).Kidney Int Suppl. 2009 Aug;(113):S1-130. doi: 10.1038/ki.2009.188. Kidney Int Suppl. 2009. PMID: 19644521
-
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109. doi: 10.1097/TP.0000000000001769. Transplantation. 2017. PMID: 28742762 Free PMC article.
-
Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.Transplantation. 2020 Apr;104(4):708-714. doi: 10.1097/TP.0000000000003137. Transplantation. 2020. PMID: 32224812 Free PMC article. Review.
-
The KDIGO review of the care of renal transplant recipient.Pol Arch Med Wewn. 2010 Jun;120(6):237-42. Pol Arch Med Wewn. 2010. PMID: 20567208 Review.
Cited by
-
Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients: Barriers and Predictors.Ann Transplant. 2021 Mar 30;26:e928356. doi: 10.12659/AOT.928356. Ann Transplant. 2021. PMID: 33782377 Free PMC article.
-
Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?J Ophthalmic Inflamm Infect. 2013 May 31;3(1):48. doi: 10.1186/1869-5760-3-48. J Ophthalmic Inflamm Infect. 2013. PMID: 23724805 Free PMC article.
-
Antiviral treatment for chronic hepatitis B in renal transplant patients.World J Hepatol. 2015 Feb 27;7(2):189-203. doi: 10.4254/wjh.v7.i2.189. World J Hepatol. 2015. PMID: 25729474 Free PMC article. Review.
-
Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait?Clin Kidney J. 2020 Jan 25;13(4):513-521. doi: 10.1093/ckj/sfz187. eCollection 2020 Aug. Clin Kidney J. 2020. PMID: 32905295 Free PMC article. Review.
-
The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study.Pediatr Nephrol. 2013 Jun;28(6):939-49. doi: 10.1007/s00467-013-2419-6. Epub 2013 Feb 17. Pediatr Nephrol. 2013. PMID: 23417277 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
